AAAAAA

   
Results: 1-14 |
Results: 14
EX-VIVO TREATMENT OF BONE-MARROW WITH PHOSPHOROTHIOATE OLIGONUCLEOTIDE OL(1)P53 FOR AUTOLOGOUS TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKEMIA AND MYELODYSPLASTIC SYNDROME
Authors: BISHOP MR JACKSON JD TARANTOLO SR OKANEMURPHY B IVERSEN PL BAYEVER E JOSHI SM SHARP JG PIERSON JL WARKENTIN PI ARMITAGE JO KESSINGER A
Citation: Mr. Bishop et al., EX-VIVO TREATMENT OF BONE-MARROW WITH PHOSPHOROTHIOATE OLIGONUCLEOTIDE OL(1)P53 FOR AUTOLOGOUS TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKEMIA AND MYELODYSPLASTIC SYNDROME, Journal of hematotherapy, 6(5), 1997, pp. 441-446
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHILDREN WITH ACUTE-LEUKEMIA - LONG-TERM FOLLOW-UP OF PATIENTS PREPARED WITH HIGH-DOSE CYTOSINE-ARABINOSIDE AND FRACTIONATED TOTAL-BODY IRRADIATION
Authors: GORDON BG WARKENTIN PI STRANDJORD SE ABROMOWITCH M BAYEVER E HARPER JL COCCIA PF
Citation: Bg. Gordon et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHILDREN WITH ACUTE-LEUKEMIA - LONG-TERM FOLLOW-UP OF PATIENTS PREPARED WITH HIGH-DOSE CYTOSINE-ARABINOSIDE AND FRACTIONATED TOTAL-BODY IRRADIATION, Bone marrow transplantation, 20(1), 1997, pp. 5-10
PHASE-I TRIAL OF AN ANTISENSE OLIGONUCLEOTIDE OL(1)P53 IN HEMATOLOGICMALIGNANCIES
Authors: BISHOP MR IVERSEN PL BAYEVER E SHARP JG GREINER TC COPPLE BL RUDDON R ZON G SPINOLO J ARNESON M ARMITAGE JO KESSINGER A
Citation: Mr. Bishop et al., PHASE-I TRIAL OF AN ANTISENSE OLIGONUCLEOTIDE OL(1)P53 IN HEMATOLOGICMALIGNANCIES, Journal of clinical oncology, 14(4), 1996, pp. 1320-1326
ENHANCED CYTOTOXICITY OF DRUG-RESISTANT ACUTE-LEUKEMIA CELLS DUE TO INTRACELLULAR BINDING OF A PHOSPHOROTHIOATE OLIGONUCLEOTIDE WITH MITOXANTRONE
Authors: BAYEVER E OLSHEFSKI R HAINES KM IVY P
Citation: E. Bayever et al., ENHANCED CYTOTOXICITY OF DRUG-RESISTANT ACUTE-LEUKEMIA CELLS DUE TO INTRACELLULAR BINDING OF A PHOSPHOROTHIOATE OLIGONUCLEOTIDE WITH MITOXANTRONE, Experimental hematology, 24(9), 1996, pp. 562-562
A STUDY OF THIOTEPA, ETOPOSIDE AND FRACTIONATED TOTAL-BODY IRRADIATION AS A PREPARATIVE REGIMEN PRIOR TO BONE-MARROW TRANSPLANTATION FOR POOR-PROGNOSIS PATIENTS WITH NEUROBLASTOMA
Authors: KAMANI N AUGUST CS BUNIN N LEAHEY A BAYEVER E GOLDWEIN J ZUSMAN J EVANS AE DANGIO G
Citation: N. Kamani et al., A STUDY OF THIOTEPA, ETOPOSIDE AND FRACTIONATED TOTAL-BODY IRRADIATION AS A PREPARATIVE REGIMEN PRIOR TO BONE-MARROW TRANSPLANTATION FOR POOR-PROGNOSIS PATIENTS WITH NEUROBLASTOMA, Bone marrow transplantation, 17(6), 1996, pp. 911-916
XENOTRANSPLANTATION - A BOLD STEP FORWARD
Authors: BAYEVER E
Citation: E. Bayever, XENOTRANSPLANTATION - A BOLD STEP FORWARD, Annals of allergy, asthma, & immunology, 75(6), 1995, pp. 461-462
FRACTIONATED TOTAL-BODY IRRADIATION PRECEDING HIGH-DOSE CYTOSINE-ARABINOSIDE AS A PREPARATIVE REGIMEN FOR BONE-MARROW TRANSPLANTATION IN CHILDREN WITH ACUTE-LEUKEMIA
Authors: KAMANI N BAYEVER E AUGUST CS BUNIN N GOLDWEIN JW DANGIO GJ
Citation: N. Kamani et al., FRACTIONATED TOTAL-BODY IRRADIATION PRECEDING HIGH-DOSE CYTOSINE-ARABINOSIDE AS A PREPARATIVE REGIMEN FOR BONE-MARROW TRANSPLANTATION IN CHILDREN WITH ACUTE-LEUKEMIA, Medical and pediatric oncology, 25(3), 1995, pp. 179-184
SELECTIVE CYTOTOXICITY TO HUMAN LEUKEMIC MYELOBLASTS PRODUCED BY OLIGODEOXYRIBONUCLEOTIDE PHOSPHOROTHIOATES COMPLEMENTARY TO P53 NUCLEOTIDE-SEQUENCES
Authors: BAYEVER E HAINES KM IVERSEN PL RUDDON RW PIRRUCCELLO SJ MOUNTJOY CP ARNESON MA SMITH LJ
Citation: E. Bayever et al., SELECTIVE CYTOTOXICITY TO HUMAN LEUKEMIC MYELOBLASTS PRODUCED BY OLIGODEOXYRIBONUCLEOTIDE PHOSPHOROTHIOATES COMPLEMENTARY TO P53 NUCLEOTIDE-SEQUENCES, Leukemia & lymphoma, 12(3-4), 1994, pp. 223-231
TREATMENT OF SEVERE APLASTIC-ANEMIA BY HEMATOPOIETIC STEM-CELL TRANSPLANTATION USING CYCLOPHOSPHAMIDE AND 600-CGY FRACTIONATED TOTAL-BODY IRRADIATION - STABLE ENGRAFTMENT IN CHILDREN AT HIGH-RISK FOR GRAFT-REJECTION
Authors: GORDON B WARKENTIN P STRANDJORD S HARPER J ABROMOWITCH M BAYEVER E GROSS T COCCIA P
Citation: B. Gordon et al., TREATMENT OF SEVERE APLASTIC-ANEMIA BY HEMATOPOIETIC STEM-CELL TRANSPLANTATION USING CYCLOPHOSPHAMIDE AND 600-CGY FRACTIONATED TOTAL-BODY IRRADIATION - STABLE ENGRAFTMENT IN CHILDREN AT HIGH-RISK FOR GRAFT-REJECTION, Experimental hematology, 22(8), 1994, pp. 691-691
IN-VIVO TREATMENT OF AUTOLOGOUS BONE-MARROW WITH OLIGONUCLEOTIDE OL(1)P53 FOR ACUTE MYELOGENOUS LEUKEMIA
Authors: WHALEN VL JACKSON JD JERSHIN B BISHOP MR TARANTOLO S BAYEVER E IVERSEN P KESSINGER A SHARP JG ARMITAGE JO WARKENTIN PI
Citation: Vl. Whalen et al., IN-VIVO TREATMENT OF AUTOLOGOUS BONE-MARROW WITH OLIGONUCLEOTIDE OL(1)P53 FOR ACUTE MYELOGENOUS LEUKEMIA, Experimental hematology, 22(8), 1994, pp. 778-778
OLIGONUCLEOTIDES IN THE TREATMENT OF LEUKEMIA
Authors: BAYEVER E IVERSEN P
Citation: E. Bayever et P. Iversen, OLIGONUCLEOTIDES IN THE TREATMENT OF LEUKEMIA, Hematological oncology, 12(1), 1994, pp. 9-14
PURGING OF PERIPHERAL-BLOOD PROGENITOR CELLS WITH ANTISENSE OLIGONUCLEOTIDE-DIRECTED AGAINST BCR-ABL FOR CHRONIC MYELOGENOUS LEUKEMIA
Authors: BISHOP MR JOSHI SS JACKSON JD WU AG SANGER WG IVERSEN PL BAYEVER E SHARP JG ZON G KESSINGER A
Citation: Mr. Bishop et al., PURGING OF PERIPHERAL-BLOOD PROGENITOR CELLS WITH ANTISENSE OLIGONUCLEOTIDE-DIRECTED AGAINST BCR-ABL FOR CHRONIC MYELOGENOUS LEUKEMIA, Blood, 84(10), 1994, pp. 10000740-10000740
ANTISENSE P53 OLIGODEOXYRIBONUCLEOTIDE FOR TREATMENT OF HUMAN MALIGNANCY
Authors: BAYEVER E HAINES K
Citation: E. Bayever et K. Haines, ANTISENSE P53 OLIGODEOXYRIBONUCLEOTIDE FOR TREATMENT OF HUMAN MALIGNANCY, Journal of cellular biochemistry, 1993, pp. 195-195
PHASE-I TRIAL OF SYSTEMIC ADMINISTRATION OF OL(1)P53 OLIGONUCLEOTIDE IN REFRACTORY ACUTE MYELOGENOUS LEUKEMIA AND ADVANCED MYELODYSPLASTIC SYNDROME
Authors: BISHOP MR BAYEVER E IVERSEN PL SHARP G SPINOLO J ZON G SMITH LJ ARNESON M RUDDON R ARMITAGE J KESSINGER A
Citation: Mr. Bishop et al., PHASE-I TRIAL OF SYSTEMIC ADMINISTRATION OF OL(1)P53 OLIGONUCLEOTIDE IN REFRACTORY ACUTE MYELOGENOUS LEUKEMIA AND ADVANCED MYELODYSPLASTIC SYNDROME, Blood, 82(10), 1993, pp. 10000443-10000443
Risultati: 1-14 |